Product brochure
Learn more about SAPIEN M3 TMVR system
Download PDF
SAPIEN M3 System
Transcatheter Mitral Valve Replacement (TMVR)
Touch more lives.
Treat more MR.
The first and only approved transseptal approach to mitral valve replacement built on proven SAPIEN technology. The SAPIEN M3 system is indicated for patients with symptomatic moderate-to-severe or severe mitral regurgitation (MR) deemed unsuitable for surgery or transcatheter edge-to-edge repair (TEER) therapy.
Learn more about the SAPIEN M3 System
Medical device for professional use
Medical device for professional use
For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).